These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22220397)

  • 21. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC study.
    Kinge B; Stordahl PB; Forsaa V; Fossen K; Haugstad M; Helgesen OH; Seland J; Stene-Johansen I
    Am J Ophthalmol; 2010 Sep; 150(3):310-4. PubMed ID: 20591399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.
    Grenga P; Lupo S; Domanico D; Vingolo EM
    Retina; 2008 Oct; 28(9):1270-5. PubMed ID: 18664938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranibizumab and diabetic macular oedema: after laser therapy.
    Prescrire Int; 2012 Mar; 21(125):66. PubMed ID: 22428185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ranibizumab in diabetic macular edema. Evaluation of functional and morphological aspects].
    Reznicek L; Cserhati S; Liegl R; Seidensticker F; Haritoglou C; Wolf A; Kampik A; Ulbig MW; Neubauer A; Kernt M
    Ophthalmologe; 2013 Jul; 110(7):645-53. PubMed ID: 23436196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microaneurysm turnover in diabetic retinopathy assessed by automated RetmarkerDR image analysis--potential role as biomarker of response to ranibizumab treatment.
    Leicht SF; Kernt M; Neubauer A; Wolf A; Oliveira CM; Ulbig M; Haritoglou C
    Ophthalmologica; 2014; 231(4):198-203. PubMed ID: 24662930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.
    Chun DW; Heier JS; Topping TM; Duker JS; Bankert JM
    Ophthalmology; 2006 Oct; 113(10):1706-12. PubMed ID: 17011952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.
    Katz G; Moisseiev E; Goldenberg D; Moisseiev J; Lomnicky Y; Abend Y; Treister G; Levkovitch-Verbin H
    Eur J Ophthalmol; 2017 Mar; 27(2):210-214. PubMed ID: 27445070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.
    Campochiaro PA; Brown DM; Awh CC; Lee SY; Gray S; Saroj N; Murahashi WY; Rubio RG
    Ophthalmology; 2011 Oct; 118(10):2041-9. PubMed ID: 21715011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema.
    Campochiaro PA; Wykoff CC; Shapiro H; Rubio RG; Ehrlich JS
    Ophthalmology; 2014 Sep; 121(9):1783-9. PubMed ID: 24768239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between visual outcomes and retinal fluid resorption in patients with diabetic macular edema treated with ranibizumab.
    Penaud B; Fajnkuchen F; Levy O; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 Dec; 40(10):839-843. PubMed ID: 29132693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema.
    Yoshitake T; Murakami T; Yoshitake S; Suzuma K; Dodo Y; Fujimoto M; Tsujikawa A
    Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):787-794. PubMed ID: 30807637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab.
    Muether PS; Droege KM; Fauser S
    Br J Ophthalmol; 2014 Feb; 98(2):179-81. PubMed ID: 24227804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic macular edema.
    Lang GE
    Ophthalmologica; 2012; 227 Suppl 1():21-9. PubMed ID: 22517122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema.
    Evoy KE; Abel SR
    Ann Pharmacother; 2013 Jun; 47(6):811-8. PubMed ID: 23656749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Real-life Data on the Treatment of Diabetic Macular Oedema in Germany].
    Wilke RGH; Finger RP; Sachs HG
    Klin Monbl Augenheilkd; 2017 Dec; 234(12):1502-1507. PubMed ID: 29232757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.